Securities Class Action

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$2.65M

Material Events

Critical Governance & Disclosure

2

Board, Voting & Shareholder Rights

3

Capital Structure & Financial Risk

0

Disclosure & Communications

24

SEC Filings

8-K

Current report

2026-11-16

View 8-K Current report on SEC.gov
8-K

Current report

2026-11-05

View 8-K Current report on SEC.gov
8-K

Current report

2026-10-27

View 8-K Current report on SEC.gov
8-K

Current report

2026-10-27

View 8-K Current report on SEC.gov
8-K

Current report

2026-08-06

View 8-K Current report on SEC.gov

Insider Transaction

No Insider Transactions found for Aclaris Therapeutics, Inc.